The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AG-K-10841     3-[2,4-dihydroxy-3-(3- methylbut-2...

Synonyms: CHEBI:66048, NSC-692930, AC1L1BJW, CTK5J8806, NSC692930, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Neobavaisoflavone

 

High impact information on Neobavaisoflavone

  • The observed relative cleavage rates with DNA and RNA substrates argue against a direct interaction of a catalytic metal ion with a 2'-hydroxy group in the endonuclease active site [1].
  • Accordingly, the 2'-hydroxy group stabilizes the phosphorane intermediate, not the departing 3'-oxyanion, by hydrogen bonding [2].
  • Hydrolysis of 2',3'-O-methyleneadenosin-5'-yl bis-5'-O-methyluridin-3'-yl phosphate: the 2'-hydroxy group stabilizes the phosphorane intermediate, not the departing 3'-oxyanion, by hydrogen bonding [2].
  • Solid phase synthesis of oligoribonucleotides using the 1-[(2-chloro-4-methyl)phenyl]-4-methoxypiperidin-4-yl (Ctmp) group for the protection of the 2'-hydroxy functions and the H-phosphonate approach [3].
  • The human enzyme, by contrast, recognizes few phosphate or 2'-hydroxy groups for aminoacylation [4].
 

Biological context of Neobavaisoflavone

  • After the introduction of a vinylsilyl tether as an intramolecular radical acceptor at the 2'-hydroxy group of 4, its atom-transfer radical cyclization reaction, followed by the treatment with TBAF gave 1'alpha-vinyluridine derivative (10) [5].
 

Anatomical context of Neobavaisoflavone

  • Novel, 2'-hydroxy derivatives of fendiline have been synthesised and their ability to induce relaxation of isolated rat small mesenteric and coronary arteries were determined [6].
  • To investigate the role of the 2'-hydroxy group at the C-13 side chain of docetaxel in the antitumor activity, we prepared several 2',2'-difluoro derivatives of docetaxel and evaluated their cytotoxicity against mouse leukemia and human tumor cell lines and their microtubule disassembly-inhibitory activity [7].
  • In an effort to continually develop potent anti-inflammatory agents, novel series of chalcones, 2'-hydroxy- and 2',5'-dihydroxychalcones were synthesized and their inhibitory effects on the activation of mast cells, neutrophils, microglial cells and macrophages were evaluated in-vitro [8].
 

Associations of Neobavaisoflavone with other chemical compounds

  • The primary site of oxidation in all species examined was on the methylene carbons of the phenethyl side chain to form the 1'- and 2'-hydroxy and 2'-oxo metabolites as determined by electrospray ionization liquid chromatography-tandem mass spectrometry [9].
  • In this study, we have examined the role of one amino acid (Glu34) in human MAO B that is thought to play a crucial role in binding to the 2'-hydroxy group of ribose in the AMP moiety of FAD [10].
 

Gene context of Neobavaisoflavone

  • Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2'-hydroxy group [11].
 

Analytical, diagnostic and therapeutic context of Neobavaisoflavone

References

  1. RNA and DNA hydrolysis are catalyzed by the influenza virus endonuclease. Klumpp, K., Doan, L., Roberts, N.A., Handa, B. J. Biol. Chem. (2000) [Pubmed]
  2. Hydrolysis of 2',3'-O-methyleneadenosin-5'-yl bis-5'-O-methyluridin-3'-yl phosphate: the 2'-hydroxy group stabilizes the phosphorane intermediate, not the departing 3'-oxyanion, by hydrogen bonding. Lönnberg, T., Korhonen, J. J. Am. Chem. Soc. (2005) [Pubmed]
  3. Solid phase synthesis of oligoribonucleotides using the 1-[(2-chloro-4-methyl)phenyl]-4-methoxypiperidin-4-yl (Ctmp) group for the protection of the 2'-hydroxy functions and the H-phosphonate approach. Sakatsume, O., Ohtsuki, M., Takaku, H., Reese, C.B. Nucleic Acids Res. (1989) [Pubmed]
  4. Recognition of tRNA backbone for aminoacylation with cysteine: evolution from Escherichia coli to human. Ming, X., Smith, K., Suga, H., Hou, Y.M. J. Mol. Biol. (2002) [Pubmed]
  5. Synthesis and radical reaction of 1'-phenylselenonucleosides. Kodama, T., Nomura, M., Shuto, S., Matsuda, A. Nucleic Acids Symp. Ser. (2000) [Pubmed]
  6. 2'-Hydroxy-fendiline analogues as potent relaxers of isolated arteries. Wilkinson, J., Foretia, D., Rossington, S., Heagerty, A., Leonard, J., Hussain, N., Austin, C. Eur. J. Pharmacol. (2007) [Pubmed]
  7. Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel. Uoto, K., Ohsuki, S., Takenoshita, H., Ishiyama, T., Iimura, S., Hirota, Y., Mitsui, I., Terasawa, H., Soga, T. Chem. Pharm. Bull. (1997) [Pubmed]
  8. Synthesis and anti-inflammatory effect of chalcones. Hsieh, H.K., Tsao, L.T., Wang, J.P., Lin, C.N. J. Pharm. Pharmacol. (2000) [Pubmed]
  9. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites. Remmel, R.P., Crews, B.C., Kozak, K.R., Kalgutkar, A.S., Marnett, L.J., Algutkar, A.S. Drug Metab. Dispos. (2004) [Pubmed]
  10. Characterization of a dinucleotide-binding site in monoamine oxidase B by site-directed mutagenesis. Kwan, S.W., Lewis, D.A., Zhou, B.P., Abell, C.W. Arch. Biochem. Biophys. (1995) [Pubmed]
  11. Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists. Ladouceur, G.H., Cook, J.H., Hertzog, D.L., Jones, J.H., Hundertmark, T., Korpusik, M., Lease, T.G., Livingston, J.N., MacDougall, M.L., Osterhout, M.H., Phelan, K., Romero, R.H., Schoen, W.R., Shao, C., Smith, R.A. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
  12. High-yield immobilization of a puromycin analogue for the solid support synthesis of aminoacyl-tRNA fragments. Nguyen-Trung, N.Q., Terenzi, S., Scherer, G., Strazewski, P. Org. Lett. (2003) [Pubmed]
  13. Prenylated isoflavanone from the roots of Erythrina sigmoidea. Nkengfack, A.E., Vouffo, T.W., Fomum, Z.T., Meyer, M., Bergendorff, O., Sterner, O. Phytochemistry (1994) [Pubmed]
 
WikiGenes - Universities